保险状态与甲状腺乳头状癌治疗范围相关
该研究基于美国国家癌症数据库2004-2015年190,298例>2mm的甲状腺乳头状癌患者,分析保险状态与诊断时高危特征及治疗方式的关系。发现无保险患者诊断时甲状腺外侵犯、淋巴血管侵犯和切缘阳性率更高,而私人保险患者更可能接受全甲状腺切除、淋巴结清扫和放射性碘治疗。
要点
- 无保险患者诊断时高危特征比例更高,私人保险患者微癌比例更高。
- 私人保险是无保险患者接受全甲状腺切除、淋巴结清扫和RAI的独立预测因素。
- 医保或医疗补助患者接受这些治疗的可能性与无保险患者无差异。
核心结论
- 私人保险患者诊断时甲状腺乳头状癌侵袭性较低,且更可能接受全甲状腺切除、淋巴结清扫和放射性碘治疗。
研究设计与样本
- 回顾性队列研究,查询美国外科医师学会国家癌症数据库,纳入2004至2015年诊断的>2mm甲状腺乳头状癌患者共190,298例。
主要发现
- 无保险患者较私人保险患者甲状腺外侵犯率更高(25.2% vs. 18.9%,p<0.001)。
- 无保险患者较私人保险患者淋巴血管侵犯率更高(16.2% vs. 12.0%,p<0.001)。
- 无保险患者较私人保险患者切缘阳性率更高(16.0% vs. 12.2%,p<0.001)。
临床怎么用
- 临床医生应确保无保险和保险不足患者获得适当的转诊和随访,以减少治疗差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Health insurance has been shown to be a key determinant in cancer care, but it is unknown as to what extent insurance status affects treatments provided to papillary thyroid cancer (PTC) patients. We hypothesized that insured patients with PTC would have lower-risk tumors at diagnosis and be more likely to receive adjuvant therapies at follow-up. Methods: The American College of Surgeons' National Cancer Database was queried to identify all patients diagnosed with PTCs >2 mm in size from 2004 to 2015. Patients were grouped according to insurance status, and frequency of high-risk features and microcarcinoma at diagnosis were assessed. Multivariable analyses were used to identify independent predictors of more extensive treatment: total thyroidectomy (vs. lobectomy), lymphadenectomy, and radioactive iodine (RAI). Results: There were 190,298 patients who met inclusion criteria; the majority of patients had private insurance (139,675 [73.4%]) and were female (144,824 [76.1%]). Uninsured patients, as compared with privately insured patients, had higher rates of extrathyroidal extension of their cancers (25.2% vs. 18.9%, p < 0.001), lymphovascular invasion (16.2% vs. 12.0%, p < 0.001), and positive margins on final pathology (16.0% vs. 12.2%, p < 0.001). Conversely, patients with private insurance were 51% more likely to have microcarcinomas at diagnosis (odds ratio [OR] = 1.51 [confidence interval {CI} 1.35-1.68], p < 0.001) than uninsured patients, controlling for demographic, socioeconomic, and hospital factors. Private insurance was an independent predictor for treatment with total thyroidectomy (OR = 1.18 [CI 1.01-1.37], p < 0.05), formal lymphadenectomy (OR = 1.22 [CI 1.09-1.36], p < 0.001), and adjuvant RAI therapy (OR = 1.35 [CI 1.18-1.54], p < 0.001) as compared with no insurance, adjusted for socioeconomic, demographic, hospital, and oncologic differences. Patients with Medicare or Medicaid were no more likely to receive these treatments than uninsured patients. Conclusions: Privately insured patients have less aggressive PTCs at diagnosis, and they are more likely to be treated with total thyroidectomy, lymphadenectomy, and RAI compared with uninsured patients. Clinicians should take caution to ensure proper referral and follow-up for under- and uninsured patients to reduce disparities in treatment.
引用
- Ullmann TM, Gray KD, Limberg J, et al. Insurance Status Is Associated with Extent of Treatment for Patients with Papillary Thyroid Carcinoma. Thyroid. 2019. PMID: 31502525. doi:10.1089/thy.2019.0245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。